Climate Change Data

NIOX Group plc

Climate Impact & Sustainability Data (2023)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:92 tCO2e/year
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:92 tCO2e/year

ESG Focus Areas

  • Employee welfare
  • Diversity and inclusion
  • Health and safety
  • Ethical conduct
  • Environmental impact

Environmental Achievements

  • Reduced scope 2 CO2 equivalent emissions from 59 tonnes in 2022 to 92 tonnes in 2023; implemented office-based initiatives to reduce waste (recycling of paper, cans, plastics, batteries, and printer toners/cartridges).

Social Achievements

  • Implemented local focus groups for employee feedback; provided training on Code of Conduct and related policies, including diversity and equality; implemented annual development plans and flexible working policies; published a regular newsletter for staff; maintained a strong whistleblowing policy and established an Ethics and Compliance Hotline; promoted transparency of relationships with healthcare providers in compliance with the US Physician Payment Sunshine Act and equivalent legislation; supported UN Universal Declaration of Human Rights; encouraged charitable fundraising by employees.

Governance Achievements

  • Maintained a strong ethical and values-driven culture; implemented policies on diversity and inclusion, the prevention of bribery and corruption, conflicts of interest, and anti-slavery; ensured full compliance with the UK Bribery Act 2010, the US Foreign Corrupt Practices Act, and other major anti-corruption legislation; carried out due diligence on new key business partners; implemented robust processes to ensure sales compliance requirements are met.

Climate Goals & Targets

Medium-term Goals:
  • Introduce a product for use by patients to manage their condition at home.
Short-term Goals:
  • Introduce FeNO testing in pharmacies and occupational health.

Environmental Challenges

  • Increasing awareness and usage of FeNO testing in primary care; competition from companies with greater financial and human resources; ensuring payer coverage and inclusion of products by health insurance schemes; managing foreign exchange fluctuations; attracting, retaining, and developing employees.
Mitigation Strategies
  • Engaging with respiratory professionals to promote the use of FeNO tests; investing in research and development to reduce costs and enhance products; implementing a market access strategy to ensure continued reimbursement; monitoring markets and making forward purchases of foreign currencies; implementing competitive compensation programs, long-term incentive plans, and robust internal communications; creating development opportunities for high-performing individuals.

Supply Chain Management

Responsible Procurement
  • Long-term partnerships with third-party suppliers; dual sourcing investigated where practicable; close working with suppliers and contract manufacturers to identify and mitigate risks; due diligence on distributors and suppliers prior to contracting with them; audits of distributors and suppliers.

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

  • NIOX Pro® device

Awards & Recognition

  • 2022 Research and Development Award
  • 2023 Best Asthma Diagnosis and Management Company